ImmunoGenomiX (IGX)
ENPICOM HAS BEEN RECOGNIZED AS ONE OF THE 15 MOST PROMISING BIOTECH STARTUPS OF EUROPE IN 2019
INTRODUCING THE IGX PLATFORM TO THE AIRR COMMUNITY
ENPICOM Launches Unique Immune Sequencing Data Analysis Platform
ENPICOM Secures Funding Round To Finalize IGX Platform Development
Survey Results: European Immunotherapy Companies Have Great Concerns Regarding Increasing Costs And Long Development Timelines
ENPICOM sets a new standard for B cell receptor repertoire analysis
Towards a Predictable Combination Therapy for Multiple Cancer Types
New Scientific Presentation: Accelerate Your Immunotherapy Target Discovery Using Immune Repertoire Sequencing
ENPICOM Team Wins Microsoft Genomics Hackathon
Scientific Poster From UKE/ENPICOM Receives Award at Annual Meeting Of DGHO
Ronald Burggrave Appointed As Sales Director
ENPICOM Presents at World Immunotherapy Congress 2018
CSO of ENPICOM Gives Keynote Lecture at ByteMAL Conference 2018
ENPICOM Receives Eurostars Award
ENPICOM releases immune repertoire sequencing analysis platform to personalize immunotherapies
EUROSTARS grants project funding for IMMUNOMONITOR consortium led by ENPICOM
ENPICOM at the 17th CIMT Annual Meeting in Mainz, Germany
ENPICOM at BioSB 2018, 4th Dutch Bioinformatics & System Biology Conference
ENPICOM FEATURED IN GENOMEWEB, WORLD’S LEADING LIFE SCIENCE TECHNOLOGY NEWS OUTLET
With new CEO ENPICOM enters its next phase
ISMB2017 / ECCB2017 in Prague
Amsterdam Data Science event
BioSB 2017 in Lunteren
RSG Symposium on Computational Genomics in Mainz, Germany
SWAT4LS 2016 in Amsterdam
ENPICOM closes license agreement with VU
ECCB 2016 in The Hague
Knowledge for Growth 2016 in Ghent, Belgium
BioSB2016 in Lunteren
